Terms: = Sarcomas AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Treatment
84 results:
1. Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort.
Vanni I; Pastorino L; Andreotti V; Comandini D; Fornarini G; Grassi M; Puccini A; Tanda ET; Pastorino A; Martelli V; Mastracci L; Grillo F; Cabiddu F; Guadagno A; Coco S; Allavena E; Barbero F; Bruno W; Dalmasso B; Bellomo SE; Marchiò C; Spagnolo F; Sciallero S; Berrino E; Ghiorzo P
J Transl Med; 2024 May; 22(1):462. PubMed ID: 38750555
[TBL] [Abstract] [Full Text] [Related]
2. Comparative study between poorly differentiated thyroid cancer and anaplastic thyroid cancer: real-world pathological distribution, death attribution, and prognostic factor estimation.
Zhang K; Wang X; Wei T; Li Z; Zhu J; Chen YW
Front Endocrinol (Lausanne); 2024; 15():1347362. PubMed ID: 38544687
[TBL] [Abstract] [Full Text] [Related]
3. ATR signaling controls the bystander responses of human chondrosarcoma cells by promoting RAD51-dependent DNA repair.
Luong NC; Kawamura H; Ikeda H; Roppongi RT; Shibata A; Hu J; Jiang JG; Yu DS; Held KD
Int J Radiat Biol; 2024; 100(5):724-735. PubMed ID: 38442236
[TBL] [Abstract] [Full Text] [Related]
4. Bilateral diffuse metastases in advanced lung adenocarcinoma harboring EGFR mutations was associated with a favorable prognosis to EGFR-TKIs.
Gu Z; Huang P; Zhao J; Luo C; Liao L; Liu A; Huang L
Int J Cancer; 2024 Jun; 154(11):1979-1986. PubMed ID: 38353428
[TBL] [Abstract] [Full Text] [Related]
5. The Biological Assessment of Shikonin and β,β-dimethylacrylshikonin Using a Cellular Myxofibrosarcoma Tumor Heterogeneity Model.
Lohberger B; Kaltenegger H; Eck N; Glänzer D; Leithner A; Kretschmer N
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958891
[TBL] [Abstract] [Full Text] [Related]
6. Clinical characteristics, treatment options, and prognosis of myeloid sarcoma: analysis using the SEER database.
Liang J; Yang L; Yang B; Tian Y; Ren J; Yang L
Hematology; 2023 Dec; 28(1):2247898. PubMed ID: 37594298
[TBL] [Abstract] [Full Text] [Related]
7. Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERate in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Pearson ADJ; Federico S; Gatz SA; Ortiz M; Lesa G; Scobie N; Gounaris I; Weiner SL; Weigel B; Unger TJ; Stewart E; Smith M; Slotkin EK; Reaman G; Pappo A; Nysom K; Norga K; McDonough J; Marshall LV; Ludwinski D; Ligas F; Karres D; Kool M; Horner TJ; Henssen A; Heenen D; Hawkins DS; Gore L; Bender JG; Galluzzo S; Fox E; de Rojas T; Davies BR; Chakrabarti J; Carmichael J; Bradford D; Blanc P; Bernardi R; Benchetrit S; Akindele K; Vassal G
Eur J Cancer; 2023 Sep; 190():112950. PubMed ID: 37441939
[TBL] [Abstract] [Full Text] [Related]
8. The FBXO32/ATR/atm axis acts as a molecular switch to control the sensitivity of osteosarcoma cells to irradiation through its regulation of EXO1 expression.
Lu Y; Huang P; Li Y; Liu W; Li J; Zhao R; Feng H; Shi C; Cao G
Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):842-852. PubMed ID: 37227155
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of vincristine-induced peripheral neuropathy in children with cancer: Turkish validity and reliability study.
Özdemir B; Gerçeker GÖ; Özdemir EZ; Yildirim BG; Ören H; Yiş U; Günay Ç; Thomas GÖ
J Pediatr Nurs; 2023; 72():185-190. PubMed ID: 37076371
[TBL] [Abstract] [Full Text] [Related]
10. Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1).
Roser E; Harter P; Zocholl D; Denschlag D; Chekerov R; Wimberger P; Kurzeder C; Hasenburg A; Muallem MZ; Mustea A; Emons G; Zeimet AG; Beck F; Arndt T; Brucker SY; Kommoss S; Heitz F; Welz J; Egger EK; Kalder M; Buderath P; Klar M; Marth C; Ulrich UA; Weigel M; Traub L; Anthuber C; Strauss H; Hanker L; Link T; Kubiak K; Melekian B; Hornung D; Pölcher M; Lampe B; Krauß T; Keilholz U; Flörcken A; Pietzner K; Sehouli J
Int J Gynecol Cancer; 2023 Feb; 33(2):223-230. PubMed ID: 36631151
[TBL] [Abstract] [Full Text] [Related]
11. Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells.
Loi M; Salvatore G; Aquilano M; Greto D; Talamonti C; Salvestrini V; Melica ME; Valzano M; Francolini G; Sottili M; Santini C; Becherini C; Campanacci DA; Mangoni M; Livi L
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430780
[TBL] [Abstract] [Full Text] [Related]
12. Cellular and Molecular Biological Alterations after Photon, Proton, and Carbon Ions Irradiation in Human Chondrosarcoma Cells Linked with High-Quality Physics Data.
Lohberger B; Barna S; Glänzer D; Eck N; Kerschbaum-Gruber S; Stasny K; Leithner A; Georg D
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232764
[TBL] [Abstract] [Full Text] [Related]
13. Alternative Lengthening of Telomeres in Cancer Confers a Vulnerability to Reactivation of p53 Function.
Macha SJ; Koneru B; Burrow TA; Zhu C; Savitski D; Rahman RL; Ronaghan CA; Nance J; McCoy K; Eslinger C; Reynolds CP
Cancer Res; 2022 Sep; 82(18):3345-3358. PubMed ID: 35947641
[TBL] [Abstract] [Full Text] [Related]
14. The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human Uterine Leiomyosarcoma.
Yang Q; Bariani MV; Falahati A; Khosh A; Lastra RR; Siblini H; Boyer TG; Al-Hendy A
Cells; 2022 Jul; 11(14):. PubMed ID: 35883603
[TBL] [Abstract] [Full Text] [Related]
15. Quercetin Augments Cisplatin-Induced Apoptosis, DNA Damage Response, and MiR-22 Expression While It Prevents DNA Repair in Osteosarcoma Cells.
Malakoti F; Majidinia M; Ahmadi Y; Yousefi B; Shanebandi D
Drug Res (Stuttg); 2022 Sep; 72(7):378-384. PubMed ID: 35724673
[TBL] [Abstract] [Full Text] [Related]
16. Advances in targeted therapy for anaplastic thyroid carcinoma.
Qian C; Jiang L; Xu S; Wang J; Tan Z; Xin Y; Ge M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 50(6):685-693. PubMed ID: 35347921
[TBL] [Abstract] [Full Text] [Related]
17. Tanshinol suppresses osteosarcoma by specifically inducing apoptosis of U2-OS cells through p53-mediated mechanism.
Yu S; Guo L; Yan B; Yuan Q; Shan L; Zhou L; Efferth T
J Ethnopharmacol; 2022 Jun; 292():115214. PubMed ID: 35331874
[TBL] [Abstract] [Full Text] [Related]
18. Methylation-mediated silencing of protein kinase C zeta induces apoptosis avoidance through atm/CHK2 inactivation in dedifferentiated chondrosarcoma.
Shimada E; Matsumoto Y; Nakagawa M; Susuki Y; Endo M; Setsu N; Fujiwara T; Iida K; Nabeshima A; Yahiro K; Kimura A; Hirose T; Kanahori M; Oyama R; Oda Y; Nakashima Y
Br J Cancer; 2022 May; 126(9):1289-1300. PubMed ID: 35017658
[TBL] [Abstract] [Full Text] [Related]
19. DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma.
Camero S; Vitali G; Pontecorvi P; Ceccarelli S; Anastasiadou E; Cicchetti F; Flex E; Pomella S; Cassandri M; Rota R; Marampon F; Marchese C; Schiavetti A; Megiorni F
Cells; 2021 Oct; 10(11):. PubMed ID: 34831178
[TBL] [Abstract] [Full Text] [Related]
20. Ouabain Induces DNA Damage in Human Osteosarcoma U-2 OS Cells and Alters the Expression of DNA Damage and DNA Repair-associated Proteins.
Yang JL; Yang MD; Chen JC; Lu KW; Huang YP; Peng SF; Chueh FS; Liu KC; Lin TS; Chen PY; Chen WJ
In Vivo; 2021; 35(5):2687-2696. PubMed ID: 34410957
[TBL] [Abstract] [Full Text] [Related]
[Next]
